Andromeda Capital’s Allergan plc AGN Stock Holding History

Andromeda Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-4,384	Closed	-$1.06M	–	267
2014 Q3	$1.06M	Buy	+4,384	New	+$981K	0.06%	229

Other funds holding AGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Andromeda Capital's AGN Position: Q4 2014 in Review

Andromeda Capital sold out of Allergan plc (AGN) in Q4 2014, closing a stake of 4,384 shares — an estimated $1.06M sold.

Andromeda Capital first reported a position in AGN in Q3 2014 and held it in 1 quarter. The position peaked at $1.06M in Q3 2014. 840 funds tracked by Wall St. Rank hold AGN as of Q4 2014.

Andromeda Capital reported no remaining Allergan plc position as of Q4 2014 after selling out during the quarter.
Andromeda Capital sold 4,384 Allergan plc shares in Q4 2014, an estimated $1.06M.
Andromeda Capital first reported a position in Allergan plc in Q3 2014 and held it in 1 quarter.
Andromeda Capital's Allergan plc position peaked at $1.06M in Q3 2014.
840 funds tracked by Wall St. Rank held Allergan plc as of Q4 2014.

Based on Andromeda Capital's 13F filing for Q4 2014, filed 17 Feb 2015.